Help us make sure that medicines reach the North Korean
households who need it the most.
We are a European managed fully certified pharmaceutical Joint
Venture in North Korea with a manufacturing plant, a team of dedicated
professionals and we want to do our part to make the world a better place.
During our 10 years of operations in North Korea, we helped provide
affordable medicines to millions of Koreans, we manufactured high
quality medicines at very lost cost for International Organizations
and provided very valuable training to many pharmaceutical companies
across the country. But with Your help, we can do more. Despite
efforts from international organisations, a majority of Koreans in
smaller towns and villages still lack access to the most basic
medicines such as aspirin, parecetamol, mebendazole, metronidazole and
many more.
Visit us at www.pyongsu.com to find out more about who we are
and what we do.
Message from Managing Director, Rémy Lardinois
Thanks to years of hard work, our company has become the only
international GMP certified manufacturer in the country. Our team of
trained professionals often provides assistance and advice to other
local pharmaceutical companies, contributing to improving the
pharmaceutical landscape of North Korea.
At present, PyongSu Pharma manufactures essential medicines for its
own pharmacy chain and NGOs. The business is growing but our
manufacturing capacity has yet to pass 50%. That means that 50% of the
time, our GMP certified production area, our pharmacists, production
specialists and quality personnel are idle. All the while, a
tremendous amount of people in the remote regions of Korea, are in
need of the most basic medicines.
It is this paradox that led me to the idea of raising funds to
manufacture essential medicines for the people of Korea. Carefully
selecting small hospitals, local clinics in villages as well as
orphanages, we can help save, and change lives.
At PyongSu, we have been manufacturing essential medicines regularly
for the past 10 years. Audited every year by French certifying agent
Certipharm, we also send samples of our products to independent
laboratories abroad upon request from our buyers. We always delivered
medicines of impeccable quality and provided a service beyond reproach.
By launching this initiative, I hope to achieve the following objectives:
Helping those who need it the most
Providing the most basic medicines to those who need the most is
something I feel very strongly about. Over the years, PyongSu donated
products to local hospitals on several occasions but I always felt we
could do more. With this initiative, I hope to help anywhere from
500,000 to 1,000,000 Korean people have access to safe and reliable
medicines manufactured by their peers. The more money is raised, the
more medicines for the people.
Promote local production
Manufacturing locally contributes to the economy. It helps a company,
such as ours, PyongSu Pharma, develop its business activities in a
challenging environment.
Local production is not only more cost effective, it reduces the
carbon footprint of the medicines and delivery terms are more
flexible. Yet, most international organizations still choose to
procure half way around the world while spending tremendous amounts of
money on expensive generics and freight costs.
This initiative hopes to encourage international organisations to
look within their ‘operating backyard’ for procurement possibilities
before choosing well-established international partners.
For more information on the medicines we manufacture, our very low
prices and how many can be helped, go to www.pyongsu.com and click on the "Make a
Difference" page.
